Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating dalbavancin versus standard antibiotic therapy for catheter-related bloodstream infections caused by Staphylococcus aureus. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalbavancin (dalbavancin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Catheter Bacteremia, Staphylococcus Aureus Infection | Phase 3 | Status: RECRUITING